AIGP0032  Liraglutide 

Molecular Formula：

C172H265N43O51

Relative Molecular Mass：

3751.26 g/mol

CAS-Number：

204656-20-2 (net)

Long-term Storage：

-20 ± 5°C

Synonyms：

NN2211; (Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37)

Sequence：

H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH acetate salt

Fields of Application：

Diabetes II  

Active Substance：

Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog. As GLP-1, liraglutide induces insulin secretion from β-cells by binding to GLP receptors in the pancreas.

Liraglutide is indicated to improve glycemic control in adults with type 2 diabetes mellitus.

This product is offered and sold solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use or sale of drugs (the “Bolar Exemption”). Aierry cannot be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of this product to comply with the relevant national rules and regulations.